Connect with us

Cannabis News

Giving Up on Legalization? – Cannabis Industry Titans Throw in the Towel on Lobbyist in Washington

Published

on


cannabis industry lobby groups

A recent report from Stat News indicates a decrease in federal lobbying efforts by cannabis industry operators. Notably, Curaleaf, a significant player in the industry, reduced its lobbying spending in Washington, D.C., by almost 40% during the first half of the year compared to its peak spending in 2019. Furthermore, both Columbia Care and Pax Labs took more drastic measures by eliminating their lobbying teams.

 

In response to this trend, Aaron Smith, co-founder and CEO of the National Cannabis Industry Association (NCIA), which actively lobbies lawmakers, expressed concern. He described it as a “cruel irony” that businesses are cutting back on government relations spending when advocacy is essential for the industry’s success.

 

The NCIA spent $100,000 on lobbying this year, according to federal filings cited by Stat, a significant decrease from the $285,000 spent during the first half of 2019. Conversely, the U.S. Cannabis Council spent $150,000 on lobbying activities in the most recent quarter and intends to keep spending at or above this amount going forward. Additionally, the group has started a super PAC to build a large and diverse coalition.

 

The American Trade Association for Cannabis and Hemp, which began lobbying in late 2019, has modestly increased its lobbying in recent months, spending $50,000 this year. In 2022, the firm paid $50,000 for an entire year of lobbying.

 

However, two firms focusing on lobbying for cannabis reforms, the Cannabis Trade Federation and the Global Alliance for Cannabis Commerce, have reportedly folded entirely, according to the report.

 

Adam Goers, the senior vice president of corporate affairs for Columbia Care, acknowledged that although there may be less company spending on lobbying, the resources allocated are now more pragmatic and focused. As the cannabis industry faces ongoing regulatory challenges, effective lobbying efforts remain critical to navigating the evolving landscape.

 

Impact of Shifting Political Landscape on Cannabis Lobbying

 

The shift in the political landscape around marijuana legalisation can be traced to decreased federal lobbying spending by cannabis business operators. While many states have legalised medical and recreational marijuana, the federal government continues to classify it as a Schedule I restricted substance, resulting in inconsistencies between state and federal legislation. Because of the glacial pace of federal marijuana legislation and the lack of universal laws, cannabis businesses have hesitated to invest resources in lobbying activities.

 

The change in political administrations can also influence cannabis lobbying. Different administrations may prioritise different issues, impacting the trajectory of federal cannabis legislation and regulations—this dynamic challenges cannabis operators seeking to shape federal policies and advocate for the industry’s interests.

 

As the cannabis industry grows and evolves, effective lobbying efforts remain crucial for influencing federal lawmakers and policymakers. Advocacy is essential for advancing federal marijuana reform, addressing banking and tax issues, and resolving industry regulatory challenges. While the decline in lobbying spending reflects the current political climate, it highlights the need for strategic and targeted advocacy efforts to ensure the long-term success and growth of the cannabis industry.

 

Challenges and Strategies for Effective Cannabis Lobbying

 

The reduced federal lobbying spending by cannabis industry operators has prompted them to reassess their strategies for effective advocacy. Navigating the complexities of the federal political landscape requires a thoughtful approach to address the challenges posed by marijuana’s current Schedule I controlled substance classification.

 

One of the critical challenges faced by cannabis operators is the lack of uniform federal regulations. The absence of clear guidelines creates uncertainty and inhibits the industry’s growth and investment potential. Effective lobbying efforts should focus on advocating for consistent and comprehensive federal regulations that align with the evolving state-level marijuana policies. By seeking clarity and standardisation in federal laws, cannabis operators can create a more stable and predictable business environment.

 

The disparity between state and federal marijuana laws also challenges the industry. To address this, lobbying efforts should promote federal legalization respecting states’ rights to implement their cannabis policies. By supporting bills that recognise and appreciate the decisions made by individual states regarding marijuana legalisation, the cannabis industry can gain broader support among lawmakers and bridge the gap between state and federal laws.

 

Furthermore, lobbying efforts should prioritise the reform of outdated federal banking and tax regulations that disproportionately burden cannabis businesses. The current restrictions on banking services and the application of Section 280E of the federal tax code limit the industry’s financial growth and viability. Advocating for fair and equitable treatment in these areas is essential for fostering the industry’s development and levelling the playing field with other sectors.

 

 

The Impact of Reduced Lobbying on the Cannabis Industry

 

The decline in federal lobbying spending by cannabis operators can impact the industry’s growth, regulatory environment, and overall competitiveness. With reduced resources dedicated to lobbying, cannabis businesses may face challenges in shaping federal policies and advancing their interests in a complex and rapidly evolving landscape.

 

One significant consequence of reduced lobbying efforts is the potential for slower progress in federal marijuana reform. Effective advocacy is critical in influencing lawmakers and policymakers to support cannabis-friendly legislation. Without sufficient lobbying, important bills addressing issues such as decriminalization, taxation, and access to financial services may face delays or more significant legislative obstacles. As a result, the cannabis industry could experience slower growth and be subject to a less favorable regulatory environment.

 

Lower lobbying spending may impact the industry’s ability to address banking and financial concerns. Access to standard financial services remains a key barrier for cannabis entrepreneurs, limiting their capacity to conduct business efficiently and safely. Practical lobbying efforts can aid in passing legislation that allows the cannabis industry better access to banking and financial services, thus levelling the playing field and establishing a more robust and stable economic environment.

 

Additionally, the reduced lobbying spending may affect the industry’s ability to advocate for social equity and inclusion within the cannabis sector. As the industry continues to grow, it is essential to ensure that it is representative and inclusive, addressing the historical disparities and injustices related to cannabis prohibition. Advocating for policies that promote diversity and social equity within the cannabis space requires dedicated resources and lobbying efforts. With reduced funding allocated to lobbying, there may be a risk of losing momentum in addressing these crucial social justice issues.

 

Bottom Line

 

The decline in federal lobbying spending by cannabis industry operators reflects the challenges and complexities they face in navigating the shifting political landscape. While some major players have reduced or eliminated their lobbying efforts, others continue to strategise and invest in advocacy to influence federal lawmakers and advance the industry’s interests. Reduced lobbying can affect the industry’s growth, regulatory environment, and social equity initiatives. As the cannabis sector evolves, effective lobbying remains critical for driving federal marijuana reform, addressing financial barriers, and fostering a diverse and inclusive industry. Successful advocacy efforts will be essential in shaping a favourable regulatory framework and ensuring the long-term success of the cannabis industry in the United States.

 

BIG PHARMA LOBBYS AGAINST WEED, READ ON…

BIG PHARMA AGAINST CANNABIS

WHY IS THE BIG PHARMA LOBBYIST AGAINST LEGALIZATION?



Source link

Cannabis News

Runners’ High or Get High to Run?

Published

on

By


running high on marijuana vs running sober

Running Sober vs. High on Marijuana: How Weed Affects Your Workout

 

As the cultural and legal landscape surrounding cannabis continues to shift, many fitness enthusiasts are exploring its potential role in exercise routines. A growing number of runners are experimenting with cannabis use before workouts, sparking debates about its impact on physical performance. Does it enhance the experience or hinder results? This article delves into the science behind running sober versus running high, examining how cannabis affects endurance, focus, and overall workout performance.

 

The Basics of Running Sober

 

Running sober has long been the standard approach for athletes and fitness enthusiasts. Without external substances, runners rely on their natural physical and mental capacities to perform. This approach offers several benefits:

 

 

When running sober, the mind remains clear, allowing athletes to concentrate fully on their pace, breathing, and surroundings. This mental clarity can be crucial for maintaining proper form and achieving peak performance.

 

 

Sober running promotes a strong connection between the mind and body. Runners can accurately gauge their exertion levels, recognize signs of fatigue, and adjust their intensity accordingly.

 

 

Without the influence of substances, sober runners experience consistent physical responses to training. This consistency makes it easier to track progress, set realistic goals, and develop effective workout plans.

 

 

The Basics of Running High

 

Running high involves consuming cannabis before a workout, typically through smoking, vaping, or ingesting edibles. Advocates claim that cannabis can enhance the running experience in various ways:

 

 

Cannabis is known for its analgesic properties, which can help reduce muscle soreness and joint pain. Some runners report that cannabis allows them to push through discomfort and extend their workouts.

 

 

Cannabis can create a sense of euphoria or relaxation, often referred to as a “runner’s high.” For some, this altered perception makes running feel more enjoyable and less monotonous.

 

 

Cannabis may enhance the brain’s ability to enter a state of flow, where the runner feels deeply immersed in the activity. This can lead to creative thinking and a stronger connection to the running experience.

 

 

The Science of Cannabis and Exercise

 

To understand the effects of cannabis on running, it’s essential to examine its active compounds and how they interact with the body.

 

 

Cannabis contains two primary compounds that affect physical and mental states which are:

  • THC (tetrahydrocannabinol): The psychoactive component responsible for the “high.” THC alters perception, mood, and coordination.

 

 

The ratio of THC to CBD in a cannabis product significantly influences its effects on a workout. Products high in THC may impair coordination, while CBD-dominant options can provide relief from pain and inflammation without causing a high.

 

 

The body’s endocannabinoid system plays a crucial role in regulating mood, pain, and inflammation. Cannabis interacts with this system, potentially enhancing its natural functions. For instance, the endocannabinoids released during exercise are thought to contribute to the “runner’s high.”

 

Benefits of Running High

 

Proponents of running high argue that cannabis offers unique benefits that can enhance the workout experience:

 

 

Cannabis’s analgesic properties make it an attractive option for runners dealing with chronic pain or soreness. By reducing discomfort, it allows athletes to train longer and recover faster.

 

 

For some, running high turns a mundane workout into an enjoyable experience. The euphoric effects of THC can make runners feel more motivated and engaged.

 

 

Cannabis’s calming effects can help reduce pre-run anxiety, particularly for individuals preparing for races or long-distance runs. This relaxation can improve performance by preventing tension and overexertion.

 

Should You Try Running High?

 

If you’re considering running high, it’s essential to approach it with caution. Start with a low dose of cannabis in a safe and familiar environment. Pay attention to how your body responds and avoid using cannabis before races or high-stakes training sessions.

 

Risks and Drawbacks of Running High

 

Despite its potential benefits, running high comes with significant risks that runners should consider:

 

 

THC can impair motor skills and reaction times, increasing the likelihood of injuries or accidents during a run. This is especially dangerous for outdoor runners navigating traffic or uneven terrain.

 

 

Cannabis may distort a runner’s perception of effort, leading them to overexert or underestimate their limits. This can result in fatigue, dehydration, or even injury.

 

 

Smoking or vaping cannabis before running can irritate the lungs and reduce oxygen intake, negatively affecting endurance and performance.

 

 

In regions where cannabis use is prohibited, running high may carry legal consequences. Additionally, athletes competing in regulated events risk disqualification if cannabis use violates anti-doping rules.

 

Comparing the Two (Running sober vs high)

 

Performance: Running sober often leads to more predictable performance, as cannabis can either enhance or hinder depending on tolerance and strain.

Safety: While weed may reduce pain, it can impair judgment, making it harder to gauge limits or react to sudden changes in the environment.

Mental State: Some runners find that cannabis helps them relax and overcome pre-run anxiety, while others feel it clouds their mental clarity.

 

Conclusion

The decision to run sober or high is deeply personal and depends on individual preferences, goals, and circumstances. Running sober offers consistency, clarity, and safety, making it ideal for competitive athletes and those focused on measurable progress. On the other hand, running high can enhance enjoyment, reduce pain, and provide a unique mental experience, making it appealing for recreational runners.

 

Ultimately, the key is to approach cannabis use thoughtfully and responsibly. Whether you choose to lace up your running shoes sober or high, prioritizing safety and listening to your body will help ensure a rewarding workout experience.

 

RUNNERS AND MARIJUANA, READ ON…

RUNNERS USING CANNABIS

HOW DOES A RUNNER’S HIGH REALLY WORK? CLICK HERE!

 



Source link

Continue Reading

Cannabis News

Two Economic Forces That are Reshaping America

Published

on

By


cannabis ai forces

Two Sectors of Society that’s Not Going Away…

You know that feeling when you’re comfortably high and suddenly have an epiphany about how rapidly the world is changing? Well, that’s exactly what happened to me recently while scrolling through Reddit, watching two separate conversations unfold about AI and cannabis – perhaps the two most transformative forces reshaping our society today.

The pace of change is dizzying, isn’t it? We’re living in an era where technological advancement isn’t just rapid – it’s exponential. Before we can fully grasp one innovation, three more have already emerged. And while some folks are still debating whether to embrace these changes, the train has not only left the station, it’s broken the sound barrier.

I found myself in the middle of a heated debate about AI in publishing, with some traditionally-minded writers clutching their pearls at the mere mention of using artificial intelligence in the creative process. The irony wasn’t lost on me – here they were, arguing on a digital platform about the evils of digital progress. Meanwhile, in another corner of Reddit, I stumbled upon a discussion about cannabis stocks, with one astute observer noting, “Cannabis ain’t going anywhere…”

And you know what? Both these threads got me thinking. These two sectors – AI and cannabis – share something fascinating in common: they’re both unstoppable forces that are fundamentally altering how we live, think, and interact with the world. Whether you’re excited about it or terrified, both are here to stay. The only real question is how we choose to integrate them into our society.

So pack a bowl, fire up your neural networks (both biological and artificial), and join me as we explore these transformative forces reshaping our world. Trust me, this is going to be one hell of a trip through the intersection of technology, consciousness, and social change.

Let me tell you something about revolution – it doesn’t always come with a bang. Sometimes it creeps in slowly, one dispensary at a time, one changed mind at a time, until suddenly you look around and realize the world isn’t what it used to be. That’s exactly what’s happened with cannabis over the past two decades.

Remember when California was the lone wolf with its medical marijuana program? These days, you can walk into a dispensary in more than half of U.S. states and legally purchase cannabis. Hell, you can even light up legally in Germany now. The transformation has been nothing short of remarkable, even if 2024 saw a slight slowdown in the legalization momentum. But make no mistake – this train isn’t stopping. It might hit some speed bumps, but it’s still chugging along toward full legalization.

Now, I know what you’re thinking: “But Reg, what about the upcoming Trump administration? Won’t that put the brakes on everything?” Look, I’ve spent enough time analyzing cannabis policy to know that nothing’s certain in politics. But here’s the interesting part – there’s actually some reason for optimism. With RFK Jr. potentially heading up Health and Human Services, we might see some surprising moves. I’ve written before about how a well-crafted legalization plan could actually be a winner with a Republican-controlled government. Tax revenue, states’ rights, personal freedom – these are concepts that resonate across party lines.

But let’s be real for a minute. Whether it happens under Trump or the next administration or the one after that, cannabis legalization is inevitable. You can’t put this genie back in the bottle. We’re talking about an industry generating billions in legal revenue annually. The cannabis sector isn’t just some hippie dream anymore – it’s a serious economic force with real jobs, real tax revenue, and real political clout.

And here’s the kicker – demographics are destiny. The reefer madness generation is fading away, replaced by millennials and Gen X parents who’d rather spark a joint than open a bottle of wine after putting the kids to bed. Cannabis has been normalized to a degree that would have been unthinkable twenty years ago. When soccer moms are discussing their favorite strains at PTA meetings and grandma is using CBD for her arthritis, you know the cultural shift is complete.

The future is clear: federal legalization in the U.S. is coming, and international legalization will follow. It’s not a matter of if, but when. And when that day comes, we’ll look back at this period of transition and wonder why it took so long to embrace what humans have known for thousands of years – that this plant has the power to heal, to inspire, and to bring people together.

You know what’s wild? While I’ve been covering cannabis for years, watching it slowly transform from counterculture to mainstream, artificial intelligence swooped in like a technological tornado and turned everything upside down practically overnight. And I mean everything.

Let me get personal for a minute. As someone who’s made their living stringing words together, I’ve had a front-row seat to this revolution. Where I used to have editors throwing assignments my way like joints at a Cypress Hill concert, nowadays those gigs have become as rare as schwag weed in a Colorado dispensary. And I’m not alone – this disruption is hitting everyone from artists to lawyers, doctors to factory workers.

Recently, I found myself in the crosshairs of this debate when I mentioned my latest project – a 90,000-word fiction book I’m creating with AI assistance. You’d think I’d announced I was mixing oregano with my cannabis, the way some people reacted. The downvotes came faster than munchies after a dab session. But here’s the thing: I’m not just feeding prompts into a machine and calling it a day. I’m channeling my creativity through this new tool, directing it like a conductor leads an orchestra. Every plot point, every character arc, every emotional beat – that’s all coming from my creative vision.

But try explaining that to the traditionalists. They insist it’s not “real” writing if AI is involved. It’s like arguing with someone who still believes in Reefer Madness – they’re so caught up in their preconceptions that they can’t see the bigger picture. The reality is, this technology isn’t going away. Just like cannabis legalization, we’re past the point of no return.

And let’s be real – this is just the beginning. While I’m catching flak for using AI in writing, companies like Tesla and Boston Dynamics are developing robots that could replace entire workforces. Couple that with AI, and suddenly you don’t need human workers, floor managers, or even middle management. It’s enough to make anyone paranoid, and this time, it’s not the weed talking.

The question isn’t whether AI will transform society – it’s already happening. The real question is what happens to those who can’t or won’t adapt. I’ve chosen to lean into it because I see the writing on the wall. In a few years, companies won’t be hiring copywriters; they’ll be hiring “prompters” who know how to dance with the AI to get results. And they’ll do it for a fraction of what they’re paying now.

Here’s the kicker though – just like cannabis, AI has the potential to either enhance our lives or cause serious problems, depending on how we handle it. The genie’s out of the bottle, folks, and it’s smoking something a lot stronger than we ever imagined. The only choice we have is whether we learn to work with it or let it work us over.

Look, I’ve been around long enough to know when something’s here to stay. Cannabis and AI aren’t just trends – they’re transformative forces reshaping our world faster than you can clear a bong. And just like that friend who says they’ll “just take one hit,” there’s no going back once you start.

The writing isn’t just on the wall anymore; it’s being projected in 8K resolution by an AI while someone blazes a joint in the corner. These industries aren’t just growing; they’re intertwining with every aspect of our lives. Fighting against this reality is like trying to push smoke back into a bowl – pointless and probably going to give you a headache.

So here’s my advice, for what it’s worth: Find your place in this brave new world. Maybe that means developing cannabis-infused products that no one’s thought of yet. Maybe it means becoming the go-to AI prompt engineer for dispensaries looking to automate their marketing. Hell, maybe it means combining both – using AI to optimize grow operations or predict cannabis market trends.

The point is, you can either evolve or get left behind, reminiscing about the “good old days” like that one uncle who still thinks “pot needles” are a thing. And let me tell you, I’ve seen enough of those folks – bitter, resistant to change, watching the world pass them by while they clutch their outdated beliefs like a security blanket.

The future is coming, whether we’re ready or not, and it’s bringing both heavy tech and heavy hits with it. You can either grab your piece of the pie or watch others feast. Personally, I’d rather be at the table than watching through the window.

Remember this: the future is red-eyed and running on neural networks, and no amount of clutching pearls or crying about “the way things used to be” is going to change that. So spark up, power up, and get ready for the ride – it’s going to be one hell of a trip.

 

HUMANS AND AI, NOT THE FIRST GO-AROUND? READ ON…

HUMANS HAD AI BEFORE

HUMANS AND AI, NOT OUR FIRST GO-AROUND? READ THIS!



Source link

Continue Reading

Cannabis News

What to Expect for Global Cannabis Law Reform in 2025

Published

on

By


As the U.S. cannabis community awaits the resumption of the DEA’s administrative law hearing on rescheduling marijuana later this month, this blog will take a glimpse at the ever-dynamic global landscape of cannabis policy. While some countries may expand, retract, or maintain the progress seen in 2024, much attention will focus on the key developments that marked the past year. Notably, Europe saw significant movement in cannabis policy.

Key global cannabis law developments in 2024

  • Germany passed a quasi-legalization law with two phases. Phase I, implemented in 2023, legalized cannabis cultivation clubs, home cultivation, and personal possession. Phase II, still in the early planning stages, would introduce regulated marijuana sales through pilot programs. The most impactful change, however, has been the expansion of medical marijuana access, which has surged since the law’s enactment.
  • Poland’s Parliamentary Committee on Petition presented a proposal to decriminalize personal marijuana possession and home cultivation to the Prime Minister. While the proposal is not binding, it could pave the way for future progress, contingent on the outcome of Poland’s May presidential election.
  • The Netherlands, after multiple delays, is poised to meet demand for regulated marijuana through licensed cultivators supplying coffee shops participating in the trial, marking a significant step in its regulated cannabis market.
  • Switzerland expanded its pilot program for the regulated sale of marijuana to more jurisdictions.
  • Ukraine legalized medical marijuana for specific qualifying conditions, marking a major health policy milestone.
  • Thailand, under its new conservative government, opted to regulate rather than reschedule marijuana.
  • Australia held a vote to legalize marijuana at the end of 2024. The vote failed by a vote of 24-13, but this was a monumental step in the country’s shift away from the war on drugs.
  • Italy’s conservative leadership has pushed to ban hemp flower-based products, prompting hemp industry advocates to call for an immediate review of the law’s compatibility with EU regulations. The European Commission’s review could determine the future of Italy’s hemp industry.

What to expect for global cannabis law developments in 2025

Despite the promising advances in 2024, 2025 may see increased resistance from conservative governments opposed to cannabis liberalization. Several countries may face setbacks or even roll back their cannabis reforms:

  • Germany: While several municipalities, including Frankfurt, are moving forward with commercial cannabis pilot programs, the Christian Conservative Party, expected to gain control after February’s snap elections, has indicated opposition to further expansion, particularly Phase II. Despite this, a poll showing 59% support for marijuana legalization suggests that a full reversal of Phase I is unlikely. Even if the Christian Conservatives take power, recriminalizing cannabis would be difficult without forming a coalition that includes pro-cannabis parties, which is unlikely. Thus, while pilot programs may be at risk, the current system isn’t likely to be reversed.
  • The Netherlands: Despite a rightward shift in the 2023 elections, the governing coalition has confirmed it will not halt the regulated coffee shop trials. Delayed by supply issues, these trials are now set to fully implement regulated sales by April of this year.
  • Thailand: Following its election win in 2023, the Pheu Thai Party which initially campaigned on placing cannabis back on the controlled substances list, has softened its stance.  The Party’s initial plans to criminalize marijuana appear to be off the table. The government is now focused on regulating the cannabis market, which may include some form of regulated commercial sales. Restrictions will likely be placed on the current unregulated market, but the shift towards regulation suggests that prohibition is not on the horizon. This move could also position Thailand for entry into the global medical marijuana trade.
  • Czech Republic: Initially aiming for full legalization of commercial cannabis, the Czech Republic shifted focus in 2024 under pressure from the EU regarding UN treaty obligations. Chechia is seeking a framework similar to Germany’s, with provisions for personal cultivation and possession limits. Additionally, the government is working on a regulatory regime for low-THC hemp (not exceeding 1%), including HHC, as part of its “Psychomodulatory Substances” regime.
  • Ukraine: Ukraine’s medical marijuana program, which has faced delays, is set to roll out in early 2025. Initially, it will only serve patients with specific forms of cancer and war-related PTSD. While access will be highly restricted, there is hope that additional conditions may be included in the future. Currently there are no medical marijuana products available to patients, but that is expected to change in early 2025.

Big picture thoughts for cannabis law in 2025

In 2025, conservative governments may pose challenges to expanding cannabis reforms. However, the full repeal of existing cannabis laws seems unlikely.

Recently, the United Nations High Commissioner for Human Rights underscored the failure of the War on Drugs and advocated for a shift toward regulatory frameworks that prioritize public health over punitive measures. These “alternative regulatory approaches” seek to reduce the influence of the black market and cartels, boost tax revenues, and fund social programs aimed at mitigating the impact of drugs on society.

Hopefully these principles will gain traction, and governments will continue moving away from the failed war on drugs in favor of common-sense cannabis regulation.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media